Olive Leaf Extract Sleep Randomized Trial: What the Evidence Says
Olive Leaf Extract Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass a
Quick Answer
Olive Leaf Extract Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 randomized trial, 1 narrative review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Olive Leaf Extract Sleep Randomized Trial: What the Evidence Says
Quick Answer
Olive Leaf Extract Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study | randomized trial | 2 | 2026-02-09 | 10.1186/s13063-026-09495-9 |
| Novel Ingredients: Hydroxytyrosol as a Neuroprotective Agent; What Is New on the Horizon? | narrative review | 3 | 2025-10-24 | 10.3390/foods14213624 |
What The Sources Report
- It was concluded that the mechanism of action of adaptogens is associated with the regulation of the HPA axis, leading to reduced levels of cortisol and subsequently modulating the key mediator of stress response. [McKinney Erin (2026); evidence level 2]
- The change in sleep duration and sleep disturbances score reduced; however, it did not show statistical significance compared to placebo, as participants with intrinsic sleep problems were excluded from the study. [McKinney Erin (2026); evidence level 2]
- Following a nutritious, well-balanced diet has been found to lower the risk of depression, whereas consuming diets high in processed and sugary foods and low in fiber and healthy fats correlates with a higher risk of depression. [Martínez-Zamora Lorena (2025); evidence level 3]
- One of the most important phytochemicals found in olive by-products is hydroxytyrosol (HXT), which has garnered attention during the last twenty years due to its important health benefits. [Martínez-Zamora Lorena (2025); evidence level 3]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is trial evidence in the current set, but population and intervention details still matter. For olive leaf extract sleep randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- McKinney Erin (2026). Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study. DOI: 10.1186/s13063-026-09495-9. PMCID: PMC12983611. PMID: 41656269. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12983611/
- Martínez-Zamora Lorena (2025). Novel Ingredients: Hydroxytyrosol as a Neuroprotective Agent; What Is New on the Horizon?. DOI: 10.3390/foods14213624. PMCID: PMC12608587. PMID: 41227598. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12608587/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed July 9, 2026 by Migaku Evidence Review
